Press Release

Indo-Irish Biotech startup CyGenica secures funding from
SOSV to accelerate cancer and rare genetic disease therapy

Learn More

Enabling SAFE, targeted & affordable
intracellular delivery of therapeutics

Learn More

Simplifying patient experience & improving
quality of life

Learn More

Molecular Nanomachines can solve the most
crucial issue facing life science

Learn More

CyVec is an engineered Molecular Nanomachine. It is
NON TOXIC and has very low immunogenicity

Learn More

It delivers molecules into living cells by drilling through the cell
membrane without damaging the cells

Learn More

It is a platform technology that can be applied to pharmaceutical,
agriculture and research reagents

Learn More

World's first Molecular Nanomachine for
delivery of gene editing toolbox

Learn More
Research Image

Building World’s Safest Therapeutics
Delivery system

At CyGenica, we focus on simplifying the patient experience and enhancing their quality of life by enabling safe, targeted, and affordable intracellular delivery of therapeutics.

Our platform is a non-toxic proprietary engineered negatively charged molecule that works just like a molecular drill. It bores through the cell membrane to deliver molecular cargoes to the nucleus without causing any harm to the cell, thus solving the most crucial issue of targeted intracellular delivery. We use our platform to develop in vitro and in vivo delivery solutions for drugs, gene editing components, and antibiotics.

CyGenica in the media

June 8, 2021

By:

Indo-Irish Biotech startup CyGenica secures funding from SOSV to accelerate cancer and rare genetic disease therapy

Readmore
Jan 09, 2020

By:

‘FedEx’ for cancer medicine, Cyca OncoSolutions wants to reduce the side effects of treatment

Readmore
Sep 23, 2019

By:

Woman entrepreneur from Odisha awarded in China for groundbreaking anti-cancer innovation

Readmore
May 13, 2018

By:

City-based Start-up brings a ray of hope for cancer patients

Readmore

Investments & Grants

Supporters

CyGenica’s CyVec platform is a proprietary engineered negatively charged molecule that works just like a molecular drill boring through the cell membrane to deliver molecular cargoes to the nucleus without causing any harm to the cell, solving the most crucial issue of targeted intracellular delivery. CyVec can be used to develop in vitro and in vivo delivery mechanisms for drugs, gene editing mechanisms and antibiotics.

Interested in collaborating with us? You can reach us on social media or through our contact form.

CONNECT

©️ 2021 CYGENICA. ALL RIGHTS RESERVE. | TERMS OF USE

Developed by: Malus Technology